This company has been marked as potentially delisted and may not be actively trading. Ocean Biomedical (OCEA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesOptions ChainShort InterestTrendsBuy This Stock OCEA vs. PTPI, TRVN, REVB, ATHX, HEPA, VIRX, SYRS, ATXI, BIOR, and BPTSYShould you be buying Ocean Biomedical stock or one of its competitors? The main competitors of Ocean Biomedical include Petros Pharmaceuticals (PTPI), Trevena (TRVN), Revelation Biosciences (REVB), Athersys (ATHX), Hepion Pharmaceuticals (HEPA), Viracta Therapeutics (VIRX), Syros Pharmaceuticals (SYRS), Avenue Therapeutics (ATXI), Biora Therapeutics (BIOR), and Biophytis (BPTSY). These companies are all part of the "pharmaceutical preparations" industry. Ocean Biomedical vs. Its Competitors Petros Pharmaceuticals Trevena Revelation Biosciences Athersys Hepion Pharmaceuticals Viracta Therapeutics Syros Pharmaceuticals Avenue Therapeutics Biora Therapeutics Biophytis Petros Pharmaceuticals (NASDAQ:PTPI) and Ocean Biomedical (NASDAQ:OCEA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, community ranking, dividends, valuation, analyst recommendations, profitability, media sentiment and risk. Which has preferable earnings and valuation, PTPI or OCEA? Petros Pharmaceuticals has higher revenue and earnings than Ocean Biomedical. Ocean Biomedical is trading at a lower price-to-earnings ratio than Petros Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPetros Pharmaceuticals$5.11M0.19-$8.16M-$119.000.00Ocean BiomedicalN/AN/A-$114.47M-$0.94-0.01 Does the MarketBeat Community prefer PTPI or OCEA? Ocean Biomedical received 3 more outperform votes than Petros Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformPetros PharmaceuticalsOutperform Votes1100.00% Underperform VotesNo VotesOcean BiomedicalOutperform Votes4100.00% Underperform VotesNo Votes Is PTPI or OCEA more profitable? Ocean Biomedical's return on equity of 0.00% beat Petros Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Petros PharmaceuticalsN/A -78.22% -23.50% Ocean Biomedical N/A N/A -931.55% Which has more risk & volatility, PTPI or OCEA? Petros Pharmaceuticals has a beta of 1.57, meaning that its share price is 57% more volatile than the S&P 500. Comparatively, Ocean Biomedical has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500. Does the media prefer PTPI or OCEA? In the previous week, Petros Pharmaceuticals and Petros Pharmaceuticals both had 1 articles in the media. Ocean Biomedical's average media sentiment score of 0.00 beat Petros Pharmaceuticals' score of -1.00 indicating that Ocean Biomedical is being referred to more favorably in the news media. Company Overall Sentiment Petros Pharmaceuticals Negative Ocean Biomedical Neutral Do institutionals and insiders hold more shares of PTPI or OCEA? 12.3% of Petros Pharmaceuticals shares are owned by institutional investors. Comparatively, 24.6% of Ocean Biomedical shares are owned by institutional investors. 12.3% of Petros Pharmaceuticals shares are owned by insiders. Comparatively, 73.5% of Ocean Biomedical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryOcean Biomedical beats Petros Pharmaceuticals on 6 of the 11 factors compared between the two stocks. Get Ocean Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for OCEA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OCEA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OCEA vs. The Competition Export to ExcelMetricOcean BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$275K$6.88B$5.57B$8.50BDividend YieldN/A2.49%5.27%4.16%P/E Ratio-0.018.4626.7519.65Price / SalesN/A262.48404.17152.14Price / CashN/A65.8538.2534.64Price / Book0.006.526.964.59Net Income-$114.47M$143.26M$3.23B$248.23M Ocean Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OCEAOcean Biomedical0.4795 of 5 stars$0.01+8.2%N/A-99.4%$275KN/A-0.01N/ANews CoveragePTPIPetros Pharmaceuticals0.2837 of 5 stars$0.03-4.8%N/A-99.7%$991K$5.11M-0.0120Short Interest ↑Gap DownTRVNTrevena1.7453 of 5 stars$1.02-3.0%$5.00+390.2%-89.8%$978K$443K-0.0240Gap UpREVBRevelation Biosciences0.4352 of 5 stars$0.87+0.7%N/A-97.8%$834KN/A0.0010Negative NewsShort Interest ↑ATHXAthersysN/AN/AN/AN/A$833K$146K0.0024HEPAHepion Pharmaceuticals0.992 of 5 stars$0.06+10.3%N/A-99.9%$689KN/A-0.0120News CoverageShort Interest ↓VIRXViracta Therapeutics1.9716 of 5 stars$0.02-8.8%$1.75+11,190.3%-97.4%$676KN/A-0.0120Gap DownSYRSSyros Pharmaceuticals3.708 of 5 stars$0.03-2.0%$3.33+13,233.3%-99.6%$671K$386K-0.01120Gap UpATXIAvenue Therapeutics2.0116 of 5 stars$0.20-22.8%N/A-94.2%$639KN/A0.014Gap DownBIORBiora Therapeutics1.7533 of 5 stars$0.14+3.1%$23.00+16,328.6%-98.0%$633K$892K-0.01120BPTSYBiophytisN/A$1.38-20.2%N/AN/A$484KN/A0.0030Short Interest ↑Gap Down Related Companies and Tools Related Companies PTPI Alternatives TRVN Alternatives REVB Alternatives ATHX Alternatives HEPA Alternatives VIRX Alternatives SYRS Alternatives ATXI Alternatives BIOR Alternatives BPTSY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OCEA) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocean Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocean Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
